TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Chiron Pharmasynth AS
Closing information (x1000 SEK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 11,613 | 7,208 | 8,108 |
Financial expenses | 30 | 56 | 133 |
Earnings before taxes | 3,619 | 2,080 | 4,503 |
Total assets | 17,784 | 13,031 | 11,252 |
Current assets | 17,752 | 12,982 | 11,156 |
Current liabilities | 5,312 | 4,457 | 4,907 |
Equity capital | 12,474 | 8,574 | 6,345 |
- share capital | 1,878 | 1,818 | 1,777 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 70.1% | 65.8% | 56.4% |
Turnover per employee | |||
Profit as a percentage of turnover | 31.2% | 28.9% | 55.5% |
Return on assets (ROA) | 20.5% | 16.4% | 41.2% |
Current ratio | 334.2% | 291.3% | 227.3% |
Return on equity (ROE) | 29.0% | 24.3% | 71.0% |
Change turnover | 4,170 | -1,090 | 3,200 |
Change turnover % | 56% | -13% | 65% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.